Published Research Studies that Validate Dieta’s Stool Imaging AI:

• Peer-Reviewed AI Accuracy Paper: Published in American Journal of Gastroenterology - this paper has been widely read by GIs, it is in the 99th percentile of views for this journal

• Study at Cedars-Sinai, demonstrated that Dieta's AI technology is as accurate as expert gastroenterologists and more effective than patients in classifying stool, marking a significant advancement in the objective measurement of digestive health outcomes. 

• Peer-Reviewed VA paper on Hepatic Encephalopathy: read here

• Study at the VA in Richmond and VCU, validation for use with cirrhosis patients

• Peer-Reviewed Mayo Clinic paper on Hepatic Encephalopathy: read here

• Study at the Mayo Clinic in Rochester, validation for use with cirrhosis patients, titrated daily lactulose doses based on Dieta AI stool imaging results

• Peer-Reviewed Cedars-Sinai paper on Ulcerative Colitis: read here

• Validated our technology for measuring IBD (Ulcerative Colitis specifically), stat sig correlation between Dieta AI output and blood CRP (lab biomarker). More here.

• Abstract: Ulcerative Colitis: Abstract | Poster Presentation

• Validated our technology for measuring IBD (Ulcerative Colitis specifically), stat sig correlation between Dieta AI output and blood CRP (lab biomarker). More here.

• Abstract: SIBO Microbiome Study: Abstract | Poster Presentation

• Validated our technology for monitoring SIBO outcomes, stat sig correlations between Dieta AI output and microbiome profiles measured by lactulose breath testing. More here.

• Abstract: Mediterranean vs. Low FODMAP Diets in IBS: Abstract

  • Dieta’s AI was used by researchers at University of Michigan GI to study the impacts of these 2 diets on IBS patients